
Cerus Corporation: shareholders and insiders
Price
$1.90
November 17, 2026Market cap $384M
What Ploutos Investor adds for Cerus
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Aug 17, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$3.1M
6 people
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan98%
- The rest2%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $3.0M by 6 people
- 2025: no buys, sold $93.5K by 1 person
- 2026: no buys, sold $3.0M by 6 people
- Aug 17, 2026Chrystal JensenChief Legal OfficerKind10b5-1
- Jul 16, 2026Vivek K JayaramanChief Executive OfficerKind10b5-1
- Jul 1, 2026Vivek K JayaramanChief Operating OfficerKind10b5-1
- Jun 30, 2026Kevin Dennis GreenChief Financial OfficerKind10b5-1
- Jun 30, 2026Kevin Dennis GreenChief Financial OfficerKind10b5-1
- Jun 30, 2026Vivek K JayaramanChief Operating OfficerKind10b5-1
- Jun 30, 2026Vivek K JayaramanChief Operating OfficerKind10b5-1
- Jun 30, 2026Chrystal JensenChief Legal OfficerKind10b5-1
- Jun 30, 2026Chrystal JensenChief Legal OfficerKind10b5-1
- Jun 30, 2026William Mariner GreenmanPresident and CEOKind10b5-1
- Jun 30, 2026William Mariner GreenmanPresident and CEOKind10b5-1
- Jun 9, 2026Eric BjerkholtDirectorKind
- Jun 2, 2026Ann LucenaDirectorKind
- Jun 2, 2026Eric BjerkholtDirectorKind
- Jun 2, 2026Jami K NachtsheimDirectorKind
- Jun 2, 2026Frank WitneyDirectorKind
- Jun 2, 2026Dean A. GregoryDirectorKind
- Jun 2, 2026Hua ShanDirectorKind
- May 29, 2026Vivek K JayaramanChief Operating OfficerKind10b5-1
- May 1, 2026Vivek K JayaramanChief Operating OfficerKind10b5-1
- Mar 12, 2026Richard J BenjaminChief Medical OfficerKind10b5-1
- Mar 12, 2026William Mariner GreenmanPresident and CEOKind10b5-1
- Mar 12, 2026Kevin Dennis GreenChief Financial OfficerKind10b5-1
- Mar 12, 2026Vivek K JayaramanChief Operating OfficerKind10b5-1
- Mar 9, 2026Richard J BenjaminChief Medical OfficerKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Chrystal JensenChief Legal Officer | 10b5-1 | 30.0K | $2.98 | $89.5K | Form 4 |
| Jul 16, 2026 | Vivek K JayaramanChief Executive Officer | 10b5-1 | 16.7K | $3.16 | $52.7K | Form 4 |
| Jul 1, 2026 | Vivek K JayaramanChief Operating Officer | 10b5-1 | 554.5K | – | – | Form 4 |
| Jun 30, 2026 | Kevin Dennis GreenChief Financial Officer | 10b5-1 | 63.6K | – | – | Form 4 |
| Jun 30, 2026 | Kevin Dennis GreenChief Financial Officer | 10b5-1 | 33.7K | $2.94 | $99.1K | Form 4 |
| Jun 30, 2026 | Vivek K JayaramanChief Operating Officer | 10b5-1 | 80.0K | – | – | Form 4 |
| Jun 30, 2026 | Vivek K JayaramanChief Operating Officer | 10b5-1 | 42.4K | $2.94 | $124.7K | Form 4 |
| Jun 30, 2026 | Chrystal JensenChief Legal Officer | 10b5-1 | 55.0K | – | – | Form 4 |
| Jun 30, 2026 | Chrystal JensenChief Legal Officer | 10b5-1 | 24.3K | $2.94 | $71.6K | Form 4 |
| Jun 30, 2026 | William Mariner GreenmanPresident and CEO | 10b5-1 | 192.5K | – | – | Form 4 |
| Jun 30, 2026 | William Mariner GreenmanPresident and CEO | 10b5-1 | 101.9K | $2.94 | $299.9K | Form 4 |
| Jun 9, 2026 | Eric BjerkholtDirector | 20.5K | $2.60 | $53.2K | Form 4 | |
| Jun 2, 2026 | Ann LucenaDirector | 60.0K | – | – | Form 4 | |
| Jun 2, 2026 | Eric BjerkholtDirector | 60.0K | – | – | Form 4 | |
| Jun 2, 2026 | Jami K NachtsheimDirector | 60.0K | – | – | Form 4 | |
| Jun 2, 2026 | Frank WitneyDirector | 60.0K | – | – | Form 4 | |
| Jun 2, 2026 | Dean A. GregoryDirector | 60.0K | – | – | Form 4 | |
| Jun 2, 2026 | Hua ShanDirector | 60.0K | – | – | Form 4 | |
| May 29, 2026 | Vivek K JayaramanChief Operating Officer | 10b5-1 | 16.7K | $3.00 | $50.0K | Form 4 |
| May 1, 2026 | Vivek K JayaramanChief Operating Officer | 10b5-1 | 16.7K | $3.00 | $50.0K | Form 4 |
| Mar 12, 2026 | Richard J BenjaminChief Medical Officer | 10b5-1 | 101.7K | $1.66 | $168.9K | Form 4 |
| Mar 12, 2026 | William Mariner GreenmanPresident and CEO | 10b5-1 | 447.8K | $1.66 | $743.3K | Form 4 |
| Mar 12, 2026 | Kevin Dennis GreenChief Financial Officer | 10b5-1 | 127.5K | $1.66 | $211.7K | Form 4 |
| Mar 12, 2026 | Vivek K JayaramanChief Operating Officer | 10b5-1 | 165.2K | $1.66 | $274.2K | Form 4 |
| Mar 9, 2026 | Richard J BenjaminChief Medical Officer | 10b5-1 | 40.4K | $1.88 | $76.0K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 2, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by CERS's officers and directors from 2006 up to November 17, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- ARK Investment Management LLCwith 1 more personShare of class8.95%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| ARK Investment Management LLCwith 1 more person | 8.95% | 17.93M | Aug 14, 20264 filings since Jan 10, 2025 | 13G/A |
Fell to 5% or less (3)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- D.E. ShawIn the quarter+47%
- Point72 (Cohen)In the quarter
- Citadel Advisors (Griffin)In the quarter
- Millennium Mgmt (Englander)In the quarter-75%
- Renaissance TechnologiesIn the quarter-42%
- AQR CapitalIn the quarter-11%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| D.E. Shaw | 5.49M | +47% | $16M | 0.01% |
| Point72 (Cohen) | 228.2K | $700.0K | 0.00% | |
| Citadel Advisors (Griffin) | 736.7K | $2.2M | 0.00% | |
| Millennium Mgmt (Englander) | 108.5K | -75% | $300.0K | 0.00% |
| Renaissance Technologies | 389.0K | -42% | $900.0K | 0.00% |
| AQR Capital | 1.88M | -11% | $5.5M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 8.23% of its shares outstanding were held short, -5.4% since the report before.
- Shares held short
- 16.63M
- 8.23%
- Since the report before17.58M on Sep 30, 2026
- -5.4%
- 9.4
- 1.77M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 89%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 6.24M
- Nov 15, 2023: Shares held short 6.05M
- Nov 30, 2023: Shares held short 5.58M
- Dec 15, 2023: Shares held short 5.30M
- Dec 29, 2023: Shares held short 4.60M
- Jan 12, 2024: Shares held short 4.23M
- Jan 31, 2024: Shares held short 4.48M
- Feb 15, 2024: Shares held short 4.32M
- Feb 29, 2024: Shares held short 4.50M
- Mar 15, 2024: Shares held short 5.07M
- Mar 28, 2024: Shares held short 5.88M
- Apr 15, 2024: Shares held short 5.92M
- Apr 30, 2024: Shares held short 5.72M
- May 15, 2024: Shares held short 6.01M
- May 31, 2024: Shares held short 6.42M
- Jun 14, 2024: Shares held short 6.63M
- Jun 28, 2024: Shares held short 7.14M
- Jul 15, 2024: Shares held short 6.83M
- Jul 31, 2024: Shares held short 6.42M
- Aug 15, 2024: Shares held short 6.38M
- Aug 30, 2024: Shares held short 6.41M
- Sep 13, 2024: Shares held short 6.63M
- Sep 30, 2024: Shares held short 7.04M
- Oct 15, 2024: Shares held short 7.35M
- Oct 31, 2024: Shares held short 7.93M
- Nov 15, 2024: Shares held short 6.92M
- Nov 29, 2024: Shares held short 6.62M
- Dec 13, 2024: Shares held short 6.71M
- Dec 31, 2024: Shares held short 7.80M
- Jan 15, 2025: Shares held short 8.72M
- Jan 31, 2025: Shares held short 8.60M
- Feb 14, 2025: Shares held short 9.31M
- Feb 28, 2025: Shares held short 10.09M
- Mar 14, 2025: Shares held short 10.24M
- Mar 31, 2025: Shares held short 9.89M
- Apr 15, 2025: Shares held short 10.49M
- Apr 30, 2025: Shares held short 9.39M
- May 15, 2025: Shares held short 8.84M
- May 30, 2025: Shares held short 9.04M
- Jun 13, 2025: Shares held short 6.72M
- Jun 30, 2025: Shares held short 7.96M
- Jul 15, 2025: Shares held short 7.39M
- Jul 31, 2025: Shares held short 7.01M
- Aug 15, 2025: Shares held short 9.74M
- Aug 29, 2025: Shares held short 6.90M
- Sep 15, 2025: Shares held short 11.02M
- Sep 30, 2025: Shares held short 6.19M
- Oct 15, 2025: Shares held short 5.17M
- Oct 31, 2025: Shares held short 5.22M
- Nov 14, 2025: Shares held short 5.72M
- Nov 28, 2025: Shares held short 5.84M
- Dec 15, 2025: Shares held short 6.24M
- Dec 31, 2025: Shares held short 6.71M
- Jan 15, 2026: Shares held short 7.14M
- Jan 30, 2026: Shares held short 6.73M
- Feb 13, 2026: Shares held short 7.82M
- Feb 27, 2026: Shares held short 7.78M
- Mar 13, 2026: Shares held short 10.51M
- Mar 31, 2026: Shares held short 11.12M
- Apr 15, 2026: Shares held short 11.20M
- Apr 30, 2026: Shares held short 11.27M
- May 15, 2026: Shares held short 18.52M
- May 29, 2026: Shares held short 10.77M
- Jun 15, 2026: Shares held short 19.70M
- Jun 30, 2026: Shares held short 12.74M
- Jul 15, 2026: Shares held short 13.69M
- Jul 31, 2026: Shares held short 14.96M
- Aug 14, 2026: Shares held short 17.33M
- Aug 31, 2026: Shares held short 17.72M
- Sep 15, 2026: Shares held short 17.99M
- Sep 30, 2026: Shares held short 17.58M
- Oct 15, 2026: Shares held short 16.63M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading53.3% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 53.3% of the shares in the reported trades were short sales, against 44.3% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 53.3%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 44.3%
- Change
- +9.0 pts
- Short sales a dayon average, of 984.1K shares
- 524.2K
- More than atof 3,666 US-listed companies, same days
- 61%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 40.4%
- Oct 12, 2026: Short sales 64.1%
- Oct 13, 2026: Short sales 33.9%
- Oct 14, 2026: Short sales 47%
- Oct 15, 2026: Short sales 29.1%
- Oct 16, 2026: Short sales 71.4%
- Oct 19, 2026: Short sales 67%
- Oct 20, 2026: Short sales 22.1%
- Oct 21, 2026: Short sales 37.6%
- Oct 22, 2026: Short sales 31.2%
- Oct 23, 2026: Short sales 56.4%
- Oct 26, 2026: Short sales 42.1%
- Oct 27, 2026: Short sales 37.1%
- Oct 28, 2026: Short sales 59.7%
- Oct 29, 2026: Short sales 60.6%
- Oct 30, 2026: Short sales 56.1%
- Nov 2, 2026: Short sales 68.5%
- Nov 3, 2026: Short sales 50.7%
- Nov 4, 2026: Short sales 41.3%
- Nov 5, 2026: Short sales 70.6%
- Nov 6, 2026: Short sales 42.4%
- Nov 9, 2026: Short sales 37.3%
- Nov 10, 2026: Short sales 47.6%
- Nov 11, 2026: Short sales 36.9%
- Nov 12, 2026: Short sales 44.3%
- Nov 13, 2026: Short sales 72.8%
- Nov 16, 2026: Short sales 57.1%
- Nov 17, 2026: Short sales 70.3%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- William Mariner GreenmanPresident and CEODirectly5.05M
- Laurence M CorashChief Scientific OfficerDirectly2.34M
- Vivek K JayaramanChief Executive OfficerDirectly2.23M
- Kevin Dennis GreenChief Financial OfficerDirectly1.06M
- Chrystal JensenChief Legal OfficerDirectly936.7K
- Richard J BenjaminChief Medical OfficerDirectly777.4K
- Carol MooreSVP Reg. & QualityDirectly501.0K
- Frank WitneyDirectorDirectly340.1K
- Jami K NachtsheimDirectorDirectly268.4K
- Eric BjerkholtDirectorDirectly261.7K
- Ann LucenaDirectorDirectly232.3K
- Hua ShanDirectorDirectly192.4K
- Dean A. GregoryDirectorDirectly146.7K
- Daniel N Swisher JRDirectorDirectly107.0K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| William Mariner GreenmanPresident and CEO | 5.05M | – | Jun 30, 2026 | Form 4 |
| Laurence M CorashChief Scientific Officer | 2.34M | – | Mar 14, 2024 | Form 4 |
| Vivek K JayaramanChief Executive Officer | 2.23M | – | Jul 16, 2026 | Form 4 |
| Kevin Dennis GreenChief Financial Officer | 1.06M | – | Jun 30, 2026 | Form 4 |
| Chrystal JensenChief Legal Officer | 936.7K | – | Aug 17, 2026 | Form 4 |
| Richard J BenjaminChief Medical Officer | 777.4K | – | Mar 12, 2026 | Form 4 |
| Carol MooreSVP Reg. & Quality | 501.0K | – | Mar 13, 2024 | Form 4 |
| Frank WitneyDirector | 340.1K | – | Jun 2, 2026 | Form 4 |
| Jami K NachtsheimDirector | 268.4K | – | Jun 2, 2026 | Form 4 |
| Eric BjerkholtDirector | 261.7K | – | Jun 9, 2026 | Form 4 |
| Ann LucenaDirector | 232.3K | – | Jun 2, 2026 | Form 4 |
| Hua ShanDirector | 192.4K | – | Jun 2, 2026 | Form 4 |
| Dean A. GregoryDirector | 146.7K | – | Jun 2, 2026 | Form 4 |
| Daniel N Swisher JRDirector | 107.0K | – | May 9, 2024 | Form 4 |
A lower bound: it counts only the 14 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- ARKGARK Genomic Revolution ETFWeight in the fund1.00%
- ARKKARK Innovation ETFWeight in the fund0.32%
- IWCiShares Micro-Cap ETFWeight in the fund0.13%
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.06%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.04%
- IWMiShares Russell 2000 ETFWeight in the fund0.02%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.02%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.01%
- VHTVanguard Health Care Index FundWeight in the fund0.01%
14 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 155
- Q4 2025: Managers 161
- Q1 2026: Managers 170
- Q2 2026: Managers 185
Institutional investors by quarter
The fund managers holding CERS, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 185 managers held 151M shares, worth $439M. During the quarter 35 opened a position, 20 closed one, 68 added and 53 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+3.0%
- ARK Investment ManagementIn the quarter-6.4%
- Vanguard Capital ManagementIn the quarter+5.3%
- Baker Bros. AdvisorsIn the quarter-36%
- D.E. ShawIn the quarter+47%
- Geode Capital ManagementIn the quarter+10%
- State StreetIn the quarter+13%
- Senvest ManagementIn the quarter+12%
- Acadian Asset ManagementIn the quarter+15%
- Sumitomo Mitsui Trust GroupIn the quarter-8.3%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 22.22M | +3.0% | $65M |
| ARK Investment Management | 17.93M | -6.4% | $52M |
| Vanguard Capital Management | 8.56M | +5.3% | $25M |
| Baker Bros. Advisors | 6.40M | -36% | $19M |
| D.E. Shaw | 5.49M | +47% | $16M |
| Geode Capital Management | 5.12M | +10% | $15M |
| State Street | 4.75M | +13% | $14M |
| Senvest Management | 4.61M | +12% | $13M |
| Acadian Asset Management | 4.27M | +15% | $12M |
| Sumitomo Mitsui Trust Group | 4.14M | -8.3% | $12M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Cerus's filings show?
Who buys and sells is one part of Cerus's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have CERS's insiders bought or sold?
From Jun 2, 2026 to Aug 17, 2026 Cerus's insiders bought 0 and sold $840.7K of shares on the market. 94% of the sales were under set 10b5-1 plans.
Which well-known managers hold CERS?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $16M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.